It activates two pathways: GLP-1 (like semaglutide) and GIP (glucose-dependent insulinotropic polypeptide)
The leftover liquid in the pen is not a secret fifth dose, and trying to use it can lead to inaccurate dosing, contamination and serious side effects
A fourth pillar, agents with cardiovascular and kidney benefit, has recently been added [5]
Semaglutide is considered off-label for the treatment of weight loss but its favourable effects have been documented in clinical studies: In a 26 week study with 703 adults, Oral Semaglutide contributed to 5% body weight reduction, which was significantly more substantial than the weight loss in the placebo group
There is no discussion of the safety profile, so it isn't possible to know if any side effects were reported," said Ward, who concluded that she would not recommend it to a patient wanting or needing to reduce blood sugar and reduce cardiovascular risk